Skip to main content

Table 1 Main clinical characteristics of patient

From: Extracorporeal membrane oxygenation for avian influenza A (H7N9) patient with acute respiratory distress syndrome: a case report and short literature review

Clinical characteristics

 

Diagnosis at admission

avian influenza A(H7N9),ARDS,Sepsis,Septic shock

H7N9-RNA

(BLF&pharynx swab)

From March 13th to March 29th:positive

Acinetobacter Baumannii

From March 17 to March 25:positive

Respiratory support

(outer court)

Time from symptoms onset to NIV (15 days);

Time from NIV to MV initiation (1 day);

Time from MV initiation to VV-ECMO initiation (2 days)

Respiratory support

(our hospital)

March 13 to 19:VV-ECMO duration

March 13 to April 6:MV

April 6 to 9:high flow oxygen through trachea cannula,oxygen flow rate:50 ~ 55 L/min

April 9 to 14:high flow oxygen through face mask,oxygen flow rate:35 ~ 40 L/min

April 14 to 17:administering oxygen inhalation through nasal catheter,oxygen flow rate:2-6 L/min

April 17 to 20:stop oxygen inhalation

Antiviral therapy

March 13 to April 1:Oseltamivir 150 mg,Bid

Anti infection treatments

March 13 to April 16:Tienam 1.0 g,Tid;Tigecycline 50 mg,Bid;Moxifloxacin 400 mg,Qd.etc. Adjust medication according to the results of culture and drug sensitivity.

Antifungal therapy

March 13 to April 11:Micafungin 50 mg,Qd.

steroid therapy

March 13 to April 11:methylprednisolon 80 mg,Bid,gradually reduced dosage.